{"id":71528,"date":"2026-09-08T08:08:18","date_gmt":"2026-09-08T12:08:18","guid":{"rendered":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/astrazeneca-copd-breakthrough-and-ge-aerospaces-11-75b-acquisition-lead-global-market-moves\/71528\/"},"modified":"2026-09-08T08:08:18","modified_gmt":"2026-09-08T12:08:18","slug":"astrazeneca-copd-breakthrough-and-ge-aerospaces-11-75b-acquisition-lead-global-market-moves","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/astrazeneca-copd-breakthrough-and-ge-aerospaces-11-75b-acquisition-lead-global-market-moves\/71528\/","title":{"rendered":"AstraZeneca COPD Breakthrough and GE Aerospace\u2019s $11.75B Acquisition Lead Global Market Moves"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>AstraZeneca (<a href=\"\/stock\/AZN\">AZN<\/a>)<\/strong> reported that its biologic <strong>tozorakimab<\/strong> reduced moderate-to-severe <strong>COPD exacerbations by up to 30%<\/strong> in Phase III trials, marking a potential first-in-class treatment for a broad patient population regardless of smoking status.<\/li>\n<li><strong>GE Aerospace (<a href=\"\/stock\/GE\">GE<\/a>)<\/strong> announced a definitive agreement to acquire <strong>Consolidated Precision Products (CPP)<\/strong> for <strong>$11.75 billion<\/strong> to secure critical casting capacity for its commercial and defense engine programs.<\/li>\n<li><strong>Philip Morris International (<a href=\"\/stock\/PM\">PM<\/a>)<\/strong> raised its full-year 2026 adjusted EPS guidance to a range of <strong>$8.35 to $8.50<\/strong>, citing favorable currency impacts and continued momentum in its smoke-free product portfolio.<\/li>\n<li><strong>UK 30-year gilt yields<\/strong> surged to <strong>5.8168%<\/strong>, the highest level since <strong>1998<\/strong>, as global inflation concerns and a massive \u00a34.25 billion bond sale pressured the country&#39;s public finances.<\/li>\n<li><strong>Boston Scientific (<a href=\"\/stock\/BSX\">BSX<\/a>)<\/strong> warned that a recent <strong>cyberattack<\/strong> will have a material impact on its Q3 and full-year 2026 results, likely causing the company to miss its previous sales and profit guidance.<\/li>\n<\/ul>\n<hr>\n<h2>Healthcare: AstraZeneca and Boston Scientific See Divergent Paths<\/h2>\n<p><strong>AstraZeneca (<a href=\"\/stock\/AZN\">AZN<\/a>)<\/strong> achieved a major milestone in respiratory medicine as its Phase III <strong>OBERON<\/strong> and <strong>TITANIA<\/strong> trials for <strong>tozorakimab<\/strong> met their primary endpoints. The drug demonstrated a <strong>30% reduction<\/strong> in moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) exacerbations in the OBERON trial and a <strong>29% reduction<\/strong> in the TITANIA trial. Unlike existing biologics that target specific inflammatory markers, tozorakimab showed efficacy across a broad population, including both <strong>current and former smokers<\/strong>, potentially addressing a massive unmet need for the nearly 400 million people globally living with COPD.<\/p>\n<p>In contrast, <strong>Boston Scientific (<a href=\"\/stock\/BSX\">BSX<\/a>)<\/strong> is grappling with the fallout of an August 25 <strong>cybersecurity incident<\/strong>. The company disclosed that the attack disrupted global manufacturing and order fulfillment, making it &quot;unlikely&quot; to meet its previously issued 2026 guidance. While major distribution centers have resumed operations at normal levels, the firm expects a <strong>material hit<\/strong> to its Q3 and full-year financial performance, though it maintains that long-term financial health remains intact.<\/p>\n<h2>Industrial &amp; Consumer: GE\u2019s Multi-Billion Deal and PMI\u2019s Guidance Lift<\/h2>\n<p><strong>GE Aerospace (<a href=\"\/stock\/GE\">GE<\/a>)<\/strong> is making a massive bet on its supply chain with the <strong>$11.75 billion acquisition<\/strong> of <strong>Consolidated Precision Products (CPP)<\/strong>. The deal, expected to close in the second half of 2027, will be funded with <strong>$7 billion in cash<\/strong> and the remainder in new debt. By bringing CPP\u2019s specialized casting capabilities in-house, GE aims to accelerate production for its next-generation engine programs and meet surging demand in the defense sector.<\/p>\n<p><strong>Philip Morris International (<a href=\"\/stock\/PM\">PM<\/a>)<\/strong> updated its 2026 outlook during the Barclays Global Consumer Conference, raising its adjusted EPS forecast from a prior range of $8.26\u2013$8.41 to <strong>$8.35\u2013$8.50<\/strong>. The upward revision is primarily driven by a <strong>favorable currency impact<\/strong> of $0.24 per share. CEO Jacek Olczak highlighted that smoke-free products now account for approximately <strong>42% of total net revenues<\/strong>, underscoring the company&#39;s successful transition away from traditional cigarettes.<\/p>\n<h2>Macro &amp; Geopolitics: UK Bond Yields and Trade Tensions<\/h2>\n<p>The <strong>UK Treasury<\/strong> faced its most expensive borrowing environment in nearly three decades, selling \u00a34.25 billion in 30-year bonds at a yield of <strong>5.8168%<\/strong>. This represents the highest yield since the Debt Management Office was established in <strong>1998<\/strong>. The spike reflects broader market anxiety over &quot;sticky&quot; inflation and the fiscal headroom available to Chancellor <strong>John Healey<\/strong> ahead of his upcoming October budget.<\/p>\n<p>On the geopolitical front, a <strong>trade war<\/strong> between Canada and the U.S. has escalated as Prime Minister <strong>Mark Carney<\/strong> implemented retaliatory tariffs effective September 8. Canada is imposing duties of up to <strong>50% on $27.6 billion<\/strong> worth of U.S. goods, including steel and electronics, in response to U.S.-led tariffs. Meanwhile, <strong>Indonesia<\/strong> is set to take 60% control of the <strong>Whoosh high-speed rail<\/strong> operator from a state-owned consortium by mid-September to restructure the project&#39;s <strong>$7.3 billion debt<\/strong>, while Chinese partners will retain their 40% stake.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways AstraZeneca (AZN) reported that its biologic tozorakimab reduced moderate-to-severe COPD exacerbations by up to 30% in Phase III [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[22368,4332,22369,5201,5227,5785,6259,7765,8563,9397,20958],"class_list":["post-71528","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-philip-morris-pm-stock-pm","tag-trade-war","tag-cpp","tag-emerging-markets","tag-healthcare","tag-uk-gilts","tag-copd","tag-astrazeneca-azn-stock-azn","tag-corporate-ma","tag-ge-aerospace-ge-stock-ge","tag-boston-scientific-bsx-stock-bsx"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/71528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=71528"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/71528\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=71528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=71528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=71528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}